Aktiesnakken — Februar 2010
-
så i realiteten kan der være tale om mange flere patienter
-
vi ved heller ikke om lægerne betaler det hele upfrony
-
-
hvis man gider at løbe industry links igennem kan man se at ifølge AKIN er det kun bioporto der har et reelt prodult til diagnose af AKI
-
der er en anden producent af markører, men AKI er vidst kun et spinn-off af det primære område
-
blot endnu en "bæk tanke"
-
ja hegu?
-
Du er Hegu!
-
det skal jo passes
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind